BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
BRAF
,
T cell receptor signaling pathway
,
Pseudomonas infection
,
Prostate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PC)1
Summary
General Info
Curated Studies
Most Correlated Studies
Pancreatic islet EndoC-bH2 cells after excision of immortalizing genes
Non-small cell lung cancer - differences between squamous cell and adenocarcinomas
Explore Curated Studies Results
Literature
Most Relevant Literature
Analysis of the CD8+ IL-10+ T cell response elicited by vaccination with the oncogenic tumor-self pr…
Structure-Aided Development of Small-Molecule Inhibitors of ENPP1, the Extracellular Phosphodiestera…
TPD52 expression increases neutral lipid storage within cultured cells.
PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stabilit…
Isoform 1 of TPD52 (PC-1) promotes neuroendocrine transdifferentiation in prostate cancer cells.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist
Evaluating the Safety and Pharmacokinetics of PC-1005 Administered Rectally to HIV-1 Seronegative Ad…
A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN …
PCS in Severe Treatment Resistant Depression
PC 360 Survivorship
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ